Contract Services Clinical Research
PolyU Researchers Discover Key Mechanism in Eye Pressure Regulation for Glaucoma Treatment
Glaucoma is one of the leading causes of visual impairment and blindness. According to statistics from the Hospital Authority, in Hong Kong, three out of e...
July 26, 2024 | News
Ractigen Therapeutics' RAG-18 Receives FDA Rare Pediatric Disease Designation for Duchenne Muscular Dystrophy
Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, announced that the U.S. Food and Drug Administration (FDA) has ...
July 26, 2024 | News
Sirnaomics Completes IND-Enabling Studies for siRNA Therapeutic STP125G Targeting ApoC3
Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”),...
July 24, 2024 | News
Duke-NUS Launches LIVE Ventures: S$20M to Commercialize Academic Research
Duke-NUS Medical School launched LIVE Ventures, a S$20 million incubation programme designed to catalyse the commercialisation of innovative acad...
July 22, 2024 | News
GCCL Launches R&D Division to Bolster Biosimilar and Clinical Trial Analysis Services
Newly established R&D division this year is expected to provide full-scale in-house R&D in addition to clinical sample analysis Including blockb...
July 17, 2024 | News
Full-Life Technologies and SK Biopharmaceuticals Ink $571.5 Million Deal for Exclusive Rights to Radiopharmaceutical FL-091
Full-Life Technologies ("Full-Life"), a fully integrated global radiotherapeutics company, announced that it has entered into a license agreement wit...
July 17, 2024 | News
Biosyngen's Groundbreaking CAR-T Therapy BRG01 Approved for Phase II Clinical Trial in China
Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation ...
July 17, 2024 | News
Sabin Vaccine Institute Launches Phase 2 Trial for Sudan Ebolavirus Vaccine in Uganda
Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against Sudan ebolavirus, with healthy volunteers receiving the single-...
July 16, 2024 | News
Everest Medicines Announces Positive Topline Data from Phase 3 Trial of Etrasimod for Ulcerative Colitis in Asia
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
July 16, 2024 | News
Senhwa Biosciences Submits IND to FDA for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors
Senhwa Biosciences, Inc. (TPEx: 6492), announced IND Submission to US FDA for the Phase I/II study of Silmitasertib (CX-4945) in combination with chemother...
July 15, 2024 | News
MSD Completes Acquisition of Eyebiotech Limited, Expands Late-Stage Pipeline with Promising Retinal Disease Treatment
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Eyebiotech Limited (EyeBio). ...
July 15, 2024 | News
National Cancer Center and University of Pennsylvania License CCR4 CAR-T Cell Therapy to ARC Therapies Inc.
The National Cancer Center (Tokyo, Japan) and The University of Pennsylvania (Philadelphia, PA, USA) have licensed patent rights directed to a ch...
July 12, 2024 | News
Thermo Fisher and NCI Join Forces to Accelerate Precision Medicine Trials for AML and MDS
To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: T...
July 12, 2024 | News
Aptamer Group's CTO Arron Tolley Discusses Strategic Milestones and Innovations in Collaboration with AstraZeneca
In an exclusive interview with BioPharma APAC, Arron Tolley, Chief Technology Officer of Aptamer Group, shares insights on the company's latest col...
July 11, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
